DAVID N ZACKS, MD PHD
Medical Practice at Wall St, Ann Arbor, MI

License number
Michigan 4301079848
Category
Medical Practice
Type
Ophthalmology
Address
Address
1000 Wall St, Ann Arbor, MI 48105
Phone
(734) 764-4190
(734) 936-2047

Personal information

See more information about DAVID N ZACKS at radaris.com
Name
Address
Phone
David Zacks
163 Edenwood Dr APT 105, Ann Arbor, MI 48103
(734) 778-0073
David Zacks, age 56
2070 Delaware Dr, Ann Arbor, MI 48103
David Zacks, age 68
284 Woodwind Dr, Bloomfield Hills, MI 48304
David Zacks
4091 Antique Ln, Bloomfield, MI 48302
David N Zacks
660 Woodward St, Detroit, MI 48226
(313) 961-2550

Professional information

David Zacks Photo 1

David Zacks, Ann Arbor MI

Specialties:
Ophthalmology, Surgery
Work:
University of Michigan Medical School
1000 Wall St, Ann Arbor, MI 48105 Ann Arbor Veterans Affairs Medical Center
2215 Fuller Rd, Ann Arbor, MI 48105
Education:
Yeshiva University (1996)


David N Zacks Photo 2

Dr. David N Zacks, Ann Arbor MI - MD (Doctor of Medicine)

Specialties:
Ophthalmology
Address:
1000 Wall St SUITE 1415, Ann Arbor 48105
(734) 763-1415 (Phone), (734) 936-8683 (Fax)
Ann Arbor Office
1000 Wall St, Ann Arbor 48105
(734) 763-8122 (Phone), (734) 763-1415 (Fax)
Certifications:
Ophthalmology, 2012
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1994
Faulkner Hospital
Mass Eye & Ear Infirm-Harvard Med Sch
Mass Eye & Ear Infirm


David Zacks Photo 3

Compositions And Methods Of Inhibiting Photoreceptor Apoptosis

US Patent:
2013005, Feb 28, 2013
Filed:
Aug 30, 2012
Appl. No.:
13/599699
Inventors:
David N. Zacks - Ann Arbor MI, US
Cagri Besirli - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 38/17, C12N 5/079, A61P 29/00, A61K 48/00, A61K 38/02, A61P 27/02
US Classification:
514 189, 514 44 R, 435375
Abstract:
The present invention provides compositions and methods to prevent apoptosis. In particular, provided herein are compositions and methods which prevent FAS-mediated photoreceptor apoptosis.


David Zacks Photo 4

Methods And Compositions For Preserving The Viability Of Photoreceptor Cells

US Patent:
2011015, Jun 30, 2011
Filed:
Aug 24, 2010
Appl. No.:
12/862234
Inventors:
DAVID ZACKS - ANN ARBOR MI, US
JOAN W. MILLER - WINCHESTER MA, US
International Classification:
A61K 39/395, A61K 38/07, A61K 38/08, A61K 38/18, A61K 31/7088, A61P 27/02
US Classification:
4241581, 514 208, 514 76, 514 44 R
Abstract:
Provided are methods and compositions for maintaining the viability of photoreceptor cells following retinal detachment. The viability of photoreceptor cells can be preserved by administering an apoptosis inhibitor to a mammal having an eye with retinal detachment. The apoptosis inhibitor maintains the viability of the photoreceptor cells until such time that the retina becomes reattached to the underlying retinal pigment epithelium and choroid. The treatment minimizes the loss of vision, which otherwise may occur as a result of retinal detachment.


David Zacks Photo 5

Compositions And Methods For Detecting And Treating Ophthalmic Disorders

US Patent:
2009008, Mar 26, 2009
Filed:
Sep 19, 2008
Appl. No.:
12/234195
Inventors:
David N. Zacks - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 38/20, C12Q 1/02, A61P 27/02
US Classification:
424 852, 435 29
Abstract:
The present invention relates to compositions and methods for the detecting, treating, and conducting research on ophthalmic disorders associated with photoreceptor cell death and/or retinal insult. In particular, the present invention provides compositions and methods for increasing IL-6 expression and/or activity (e.g., exogenous IL-6), activating IL-6 receptors (e.g., IL-6R, sIL6-R), activating pathway related compounds (e.g., STAT, FLIP), and/or activating related pathways (e.g., JAK/STAT pathway, TGF-β pathway, Ahr pathway) in the diagnosis, treatment, and conducting research of ophthalmic disorders associated with photoreceptor cell death and/or retinal insult (e.g., retinal detachment).


David Zacks Photo 6

Methods For Preserving The Viability Of Photoreceptor Cells By Anti-Fas-Ligand/Anti-Fas-Receptor Antibodies

US Patent:
7811832, Oct 12, 2010
Filed:
Jul 16, 2004
Appl. No.:
10/892787
Inventors:
David Zacks - Ann Arbor MI, US
Joan W. Miller - Winchester MA, US
Assignee:
Massachusetts Eye and Ear Infirmary - Boston MA
International Classification:
G01N 33/53, A61K 49/16, A61K 38/00, A61K 39/395, A61K 39/00, C12N 5/00, C12N 5/079, C12N 5/071
US Classification:
436547, 436548, 514 2, 424 92, 4241301, 4241421, 435368, 435366
Abstract:
Provided are methods and compositions for maintaining the viability of photoreceptor cells following retinal detachment. The viability of photoreceptor cells can be preserved by administering an apoptosis inhibitor to a mammal having an eye with retinal detachment. The apoptosis inhibitor maintains the viability of the photoreceptor cells until such time that the retina becomes reattached to the underlying retinal pigment epithelium and choroid. The treatment minimizes the loss of vision, which otherwise may occur as a result of retinal detachment.


David Zacks Photo 7

Methods Of Inhibiting Photoreceptor Apoptosis

US Patent:
8343931, Jan 1, 2013
Filed:
Mar 3, 2010
Appl. No.:
12/716986
Inventors:
David Noam Zacks - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61P 27/02, C07K 7/08
US Classification:
514 208, 530327
Abstract:
The present invention provides methods to prevent photoreceptor death. In particular, the present invention provides peptides which prevent FAS-mediated photoreceptor apoptosis.


David Zacks Photo 8

Methods Of Inhibiting Photoreceptor Apoptosis

US Patent:
2013012, May 16, 2013
Filed:
Jan 8, 2013
Appl. No.:
13/691074
Inventors:
David Noam Zacks - Ann Arbor MI, US
International Classification:
A61K 38/10
US Classification:
514 189
Abstract:
The present invention provides methods to prevent photoreceptor death. In particular, the present invention provides peptides which prevent FAS-mediated photoreceptor apoptosis.